Preparation of biofunctional textiles by surface functionalization based on the nanoencapsulation technique.

L'abstract è presente nell'allegato / the abstract is in the attachmen

LA DEMATERIALIZZAZIONE DELLA DOCUMENTAZIONE AMMINISTRATIVA

Quaderno monografico CNIPA n. 2

Policistosi renale: il punto di vista del pediatra

Fra le malattie renali di tipo cistico, il rene policistico dominante (ADPKD) e quello recessivo (ARPKD) sono, senza dubbio, le più conosciute. In realtà, in pediatria, le cisti renali, sono rappresentate in diversi quadri clinici, spesso sindromici, quasi sempre in ambito di malattie rare. In questo lavoro, vengono affrontati, in particolare, due diversi aspetti riguardanti il rene policistico, sia dominante che recessivo, in età pediatrica. Nella prima parte, abbiamo considerato similitudini e differenze tra la policistosi dominante e quella recessiva, che possono rendere difficile la diagnosi differenziale in età pediatrica, specialmente quando la forma dominante si manifesta in età molto precoce. Nella seconda parte, abbiamo valutato l'incidenza di ipertensione nella popolazione pediatrica con ADPKD. L'ipertensione è, di fatto uno dei segni clinici principali di entrambe le forme, ma nella popolazione pediatrica affetta da policistosi dominante, questa potrebbe essere sottostimata. Recentemente, è stata riportata una incidenza di ipertensione in pazienti pediatrici con ADPKD pari al 20% circa. Dati preliminari relativi a pazienti pediatrici con ADPKD seguiti presso l'Ospedale Pediatrico Bambino Gesù di Roma, mostrano una incidenza pari al 19%. A tale proposito, noi riteniamo che siano necessari studi rigorosi per confermare o meno questo dato allo scopo di prevenire in modo efficace le principali complicanze della ipertensione arteriosa, quali l'ipertrof a ventricolare sinistra e la retinopatia ipertensiva

Null-Space Minimization of Center of Gravity Displacementof a Redundant Aerial Manipulator

Displacements of the base during trajectory tracking are a common issue in the control of aerial manipulators. These are caused by reaction torques transferred to the base due to the manipulator motion and, in particular, to the motion of its center of gravity. We present a novel approach to reduce base displacements of a kinematically redundant aerial manipulator by using null-space projection in the inverse kinematic control. A secondary objective function minimizes the horizontal displacement of the manipulator center of gravity. We test this algorithm on different trajectories for both three and four degrees of freedom (DOF) manipulators in a simulation environment. The results comparing our algorithm with inverse kinematic control without the null-space projection show up to an 80% reduction in the end-effector position error and an average of about 56% reduction in maximum base displacement. The simulation implementation also runs faster than in real-time in our code implementation. We provide a workspace analysis based on multiple stopping criteria such as excessive base displacement, joint velocities and end-effector position error for the 3 and 4 DOF manipulators. As expected, the 4 DOF manipulator has a larger workspace

Functionalization of cotton fabrics with polycaprolactone nanoparticles for transdermal release of melatonin

Drug delivery by means of transdermal patches raised great interest as a non-invasive and sustained therapy. The present research aimed to design a patch for transdermal delivery of melatonin, which was encapsulated in polycaprolactone (PCL) nanoparticles (NPs) by employing flash nanoprecipitation (FNP) technique. Melatonin-loaded PCL nanoparticles were successfully prepared with precise control of the particle size by effectively tuning process parameters. The effect of process parameters on the particle size was assessed by dynamic light scattering for producing particles with suitable size for transdermal applications. Quantification of encapsulated melatonin was performed by mean of UV spectrophotometry, obtaining the estimation of encapsulation efficiency (EE%) and loading capacity (LC%). An EE% higher than 80% was obtained. Differential scanning calorimetry (DSC) analysis of NPs was performed to confirm effective encapsulation in the solid phase. Cotton fabrics, functionalized by imbibition with the nano-suspension, were analyzed by scanning electron microscopy to check morphology, adhesion and distribution of the NPs on the surface; melatonin transdermal release from the functionalized fabric was performed via Franz’s cells by using a synthetic membrane. NPs were uniformly distributed on cotton fibres, as confirmed by SEM observations; the release test showed a continuous and controlled release whose kinetics were satisfactorily described by Baker–Lonsdale model

Evaluation of bovine beta casein polymorphism in two dairy farms located in northern Italy

Bovine beta casein A1 is one of the most common variants in dairy cattle breeds; it is considered a risk factor in milk intolerance and in other important human diseases, because of the bioactive peptide beta casomorphin-7 (BCM7) produced by raw or processed A1-milk, but not by A2-milk, during digestion. The aim of this study was to perform a cheap and rapid method to investigate beta casein polymorphism in copious animals. The study included 2 dairy farms with a totally of 1230 cows. Beta casein genotypes were estimated evaluating Exon 7 region of bovine beta casein gene (CSN2) by sequences analysis. In the population included in the study 5 variants (A1, A2, B, F, I) and 13 genotypes (A1A1, A1A2, A1B, A1F, A1I, A2A2, A2B, A2F, A2I, BB, BF, BI, FI) were detected. The method showed high sensibility and specificity, resulted low-cost and few time consuming

Economic implications in inflammatory bowel disease: results from a retrospective analysis in an Italian Centre

BACKGROUND: Inflammatory bowel disease (IBD) represents a group of chronic conditions characterized by elevated costs. Over the last years, also a considerable healthcare burden associated with IBD has emerged, due to an increasing use of biological drugs and hospitalization costs. Despite the creation of local or regional databases, data regarding healthcare expenditure are lacking in Italy.AIM: To evaluate the treatment cost (biological drugs and hospitalizations) for patients with ulcerative colitis (UC) or Crohn’s disease (CD) treated with biological drugs.METHODS: Disease severity was evaluated by clinical scores (partial Mayo score and Harvey Bradshaw Index). We analyzed retrospectively patients treated with biologics referred to our IBD Unit between May 2015-April 2016 who underwent at least six months of follow-up (last visit October 2016). We calculated a mean cost per month of treatment for each patient. We also investigated the presence of any correlation between the monthly cost of treatment and demographic or clinical variables.RESULTS: We enrolled 142 patients (52 UC, mean age 44.3 years, male 40.4%; 90 CD, mean age 38.8 years, male 56.7%). About half of CD patients (48.9%) underwent previous intestinal surgery. The disease severity was higher in UC group vs CD group. In UC group infliximab was the most prescribed biologic (51.9%), followed by golimumab (26.9%) and adalimumab (21.2%). While CD patients were treated with adalimumab in 54.4% and infliximab in 45.6%. The mean monthly cost of treatment was € 1,235.41 ± 358.38 for UC and € 1,148.92 ± 337.36 for CD (p = 0.16). In both groups expenditure due to biologics amounts for more than 80%. We found a correlation between costs and disease activity (UC: p < 0.01; CD: p < 0.01).CONCLUSION: The main cost is due to biological drugs, but patients enrolled were the most severe in comparison to the whole IBD population under conventional therapy. As no cost differences were found between biologic drugs and the way of administration (intravenous or subcutaneous), the therapeutic choice should be driven by clinical reasons and not only economic ones

Removal of pharmaceutically active compounds using low-pressure membrane processes

This is an Accepted Manuscript of an article published by Taylor & Francis in Desalination and water treatment on 2017, available online: http://doi.org/10.5004/dwt.2017.0449[EN] The increasing demand on water resources throughout the world has motivated researchers to seek new ways to obtain quality water increasing their interest in water reclamation. However, the presence of harmful organic chemicals such as pharmaceutically active compounds (PhACs) is a serious environmental concern. The objective of this study was to investigate the influence of the pH on the rejection of seven target PhACs (acetaminophen, caffeine, erythromycin, ibuprofen, naproxen, sulfamethoxazole, and trimethoprim) by different low-pressure membranes within the fine ultrafiltration (UF) and loose nanofiltration (NF) range. For this purpose, three ceramic membranes and a polyamide membrane were used for UF and NF experiments, respectively. Experimental results indicated that PhACs with negative charge were effectively rejected at basic conditions (< 75% for UF, < 90% for NF), improving both their hydrophilicity and solubility with increasing pH. Furthermore, high soluble PhACs with high pKa values showed low rejection values (similar to 15% for UF, similar to 30% for NF) and a pH-independent behaviour during low-pressure filtration experiments. Therefore, the use of low-pressure membranes could be considered as an appropriate and sustainable supplemental technique to remove PhACs in a wastewater treatment plant.The authors of this work wish to gratefully acknowledge the financial support from the Spanish Ministry of Economy and Competitiveness through the project CTM2013-42342-P.García-Ivars, J.; Iborra Clar, MI.; Massella, M.; Carbonell Alcaina, C.; Alcaina-Miranda, MI. (2017). Removal of pharmaceutically active compounds using low-pressure membrane processes. Desalination and Water Treatment. 69:252-260. https://doi.org/10.5004/dwt.2017.0449S2522606